The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
T helper cell‐independent neutralizing B cell response against vesicular stomatitis virus: Role of antigen patterns in B cell induction?
Abstract
The neutralizing antibody response against vesicular stomatitis virus (VSV) was studied to analyze conditions necessary for induction of mature B cells. The glycoprotein of VSV (VSV‐G) is expressed as repetitive epitopes that are in a rigid densely packed paracristalline form in the virus envelope; in contrast, VSV‐G is present in a mobile randomly ordered form on infected cells and in micelles. We found that the rigid, paracristalline form of VSV‐G spaced about 5–10 mm on VSV virons induced potent primary and secondary neutralizing B cell responses which were independent of T helper cells, whereas the more randomly distributed, mobile forms of VSV‐G induced primary and secondary B cell responses that were more tightly controlled by T helper cells. These data suggest that (i) cross‐linking is a critical signal for B cell activation and antibody production, and that this signal alone does not necessarily anergize or delete mature B cells, (ii) the more regularly and rigidly ordered in a distance of 5–10 nm repetitive identical antigenic determinants are, the less are primary and secondary B cell responses controlled by T cells. We therefore propose that B cells take antigen organization as a marker for foreigness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Protection: The Unit of Humoral Immunity Selected by Evolution
Cohn, M., & Langman, R. E. (1990) · Immunological Reviews · doi:10.1111/j.1600-065x.1990.tb00783.x · Cited by 238
Cited by
Junt, T., Moseman, E. A., Iannacone, M., Massberg, S., Lang, P. A., Boes, M., Fink, K., Henrickson, S. E., Shayakhmetov, D. M., Di Paolo, N. C., et al. (2007) · Nature · doi:10.1038/nature06287 · Cited by 846
CAPTURE AND PROCESSING OF EXOGENOUS ANTIGENS FOR PRESENTATION ON MHC MOLECULES
Watts, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.821 · Cited by 763
Zinkernagel, R. M. (1996) · Science · doi:10.1126/science.271.5246.173 · Cited by 651
Self-citationNatural antibodies and complement link innate and acquired immunity
Ochsenbein, A. F., & Zinkernagel, R. M. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01754-0 · Cited by 537
Self-citationImmunogenicity of Therapeutic Protein Aggregates
Moussa, E. M., Panchal, J. P., Moorthy, B. S., Blum, J. S., Joubert, M. K., Narhi, L. O., & Topp, E. M. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.002 · Cited by 529
(2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.00607.x · Cited by 472
NEUTRALIZING ANTIVIRAL B CELL RESPONSES
Bachmann, M. F., & Zinkernagel, R. M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.235 · Cited by 471
Self-citationThe coming of age of virus-like particle vaccines
Jennings, G. T., & Bachmann, M. F. (2008) · bchm · doi:10.1515/bc.2008.064 · Cited by 369
Self-citationLiposomes and virosomes as delivery systems for antigens, nucleic acids and drugs
Felnerova, D., Viret, J.-F., Glück, R., & Moser, C. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.10.005 · Cited by 296
Virus-based nanoparticles (VNPs): Platform technologies for diagnostic imaging☆
MANCHESTER, M., & SINGH, P. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.014 · Cited by 292
IgM in microbial infections: Taken for granted?
Racine, R., & Winslow, G. M. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.06.003 · Cited by 268
The Role of Antibody Concentration and Avidity in Antiviral Protection
Bachmann, M. F., Kalinke, U., Althage, A., Freer, G., Burkhart, C., Roost, H.-P., Aguet, M., Hengartner, H., & Zinkernagel, R. M. (1997) · Science · doi:10.1126/science.276.5321.2024 · Cited by 267
Self-citationRecent progress in adjuvant discovery for peptide-based subunit vaccines
Azmi, F., Ahmad Fuaad, A. A. H., Skwarczynski, M., & Toth, I. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27332 · Cited by 239
“Moreover, the particulate forms of IRIV enable them to present the antigen to the immune system in a repetitive array to further enhance the immune response.(92) The potential use of virosomes as an adjuvant has been investigated for peptide based vaccines against numerous diseases including malaria,(93) hepatitis C,(…”
BackgroundMuri, J., Thut, H., Bornkamm, G. W., & Kopf, M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.070 · Cited by 198
“Qb-VLPs not only trigger vigorous antibodies responses but also induce GC reactions, such as hypermutations, affinity maturation, and B cell memory (Bachmann et al., 1995; Bachmann and Zinkernagel, 1997; Jennings and Bachmann, 2008).”
BackgroundInduction of long-lived germinal centers associated with persisting antigen after viral infection.
Bachmann, M. F., Odermatt, B., Hengartner, H., & Zinkernagel, R. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.2259 · Cited by 194
“This, however, appears to be a common characteristic o f many pathogens (35-37).”
BackgroundSelf-citationHennrich, A. A., Sawatsky, B., Santos-Mandujano, R., Banda, D. H., Oberhuber, M., Schopf, A., Pfaffinger, V., Wittwer, K., Riedel, C., Pfaller, C. K., et al. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009064 · Cited by 30
Metadata
- Authors
- Bachmann, M. F., Hengartner, H., & Zinkernagel, R. M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1995-12
- Volume
- 25
- Issue
- 12
- Pages
- 3445-3451
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1979707388
- Cited by
- 176
- References
- 1
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.